Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States

被引:9
作者
Wadsworth, Elle [1 ]
Hines, Lindsey A. [2 ,3 ]
Hammond, David [1 ]
机构
[1] Univ Waterloo, Sch Publ Hlth Sci, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada
[2] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England
[3] Univ Bristol, Bristol Med Sch, Integrat Epidemiol Unit, Bristol, Avon, England
基金
英国惠康基金; 加拿大健康研究院;
关键词
Opioids; pain; cannabis; marijuana; legalization; substitution; MARIJUANA; LEGALIZATION; DEATHS; LAWS;
D O I
10.1080/08897077.2022.2060431
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: With increased liberalization of cannabis policies in North America, there is growing interest in the use of cannabis to manage pain instead of opioids. The objectives of the study were to (1) examine the use of cannabis for pain relief in Canada and the United States (US) in 2018 and 2019; (2) examine the association between recreational cannabis laws and changes in the use of cannabis for pain relief, instead of opioids or prescription pain medication. Methods: Repeat cross-sectional survey data were used from Wave 1 and Wave 2 of the International Cannabis Policy Study conducted in 2018 and 2019 in Canada and the US. Respondents were recruited through commercial panels, aged 16-65, and had ever tried cannabis (N = 44,119). Weighted binary logistic regression models examined the association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication (n = 15,092). Results: Between 14-33% of cannabis consumers in Canada and the US reported using cannabis to manage headaches or pain. Of these consumers, 79% and 78% respondents in Canada; 80% and 83% in US illegal states; and 83% and 84% in US legal states, in 2018 and 2019, respectively, reported cannabis use for pain relief instead of opioids or prescription pain medication. There was little evidence of an association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication, among Canadian (AOR = 0.98, 95% CI: 0.78, 1.22) and US respondents (AOR = 1.11, 95% CI: 0.96, 1.28). Conclusions: Although substitution of cannabis for opioids or prescription pain medication is common among those who use cannabis for pain, there does not seem to be a significant difference according to cannabis legality. Future research should examine cannabis and opioid substitution using different research designs and time frames.
引用
收藏
页码:943 / 948
页数:6
相关论文
共 31 条
[21]   Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis [J].
Nielsen, Suzanne ;
Sabioni, Pamela ;
Trigo, Jose M. ;
Ware, Mark A. ;
Betz-Stablein, Brigid D. ;
Murnion, Bridin ;
Lintzeris, Nicholas ;
Khor, Kok Eng ;
Farrell, Michael ;
Smith, Andrew ;
Le Foll, Bernard .
NEUROPSYCHOPHARMACOLOGY, 2017, 42 (09) :1752-1765
[22]   The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms A Systematic Review [J].
Nugent, Shannon M. ;
Morasco, Benjamin J. ;
O'Neil, Maya E. ;
Freeman, Michele ;
Low, Allison ;
Kondo, Karli ;
Elven, Camille ;
Zakher, Bernadette ;
Motu'apuaka, Makalapua ;
Paynter, Robin ;
Kansagara, Devan .
ANNALS OF INTERNAL MEDICINE, 2017, 167 (05) :319-+
[23]   Do medical marijuana laws reduce addictions and deaths related to pain killers? [J].
Powell, David ;
Pacula, Rosalie Liccardo ;
Jacobson, Mireille .
JOURNAL OF HEALTH ECONOMICS, 2018, 58 :29-42
[24]   Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever [J].
Shi, Yuyan .
DRUG AND ALCOHOL DEPENDENCE, 2017, 173 :144-150
[25]   Association between medical cannabis laws and opioid overdose mortality has reversed over time [J].
Shover, Chelsea L. ;
Davis, Corey S. ;
Gordon, Sanford C. ;
Humphreys, Keith .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (26) :12624-12626
[26]   Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations [J].
Smart, Rosanna ;
Pacula, Rosalie Liccardo .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (06) :644-663
[27]   Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies [J].
Stockings, Emily ;
Campbell, Gabrielle ;
Hall, Wayne D. ;
Nielsen, Suzanne ;
Zagic, Dino ;
Rahman, Rakin ;
Murnion, Bridin ;
Farrell, Michael ;
Weier, Megan ;
Degenhardt, Louisa .
PAIN, 2018, 159 (10) :1932-1954
[28]   Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID-19 [J].
Tattan-Birch, Harry ;
Marsden, John ;
West, Robert ;
Gage, Suzanne H. .
ADDICTION, 2021, 116 (05) :982-984
[29]   Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study [J].
Vigil, Jacob M. ;
Stith, Sarah S. ;
Adams, Ian M. ;
Reeve, Anthony P. .
PLOS ONE, 2017, 12 (11)
[30]   Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees [J].
Wen, Hefei ;
Hockenberry, Jason M. .
JAMA INTERNAL MEDICINE, 2018, 178 (05) :673-679